Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas
Purpose: Glioblastoma (GBM) remains an incurable disease despite extensive treatment with surgical resection, irradiation, and temozolomide. In line with many other forms of aggressive cancers, GBM is currently under consideration as a target for immunotherapy. However, GBM tends to be nonimmunogeni...
Main Authors: | Jean Philippe Nesseler, MD, Dorthe Schaue, PhD, William H. McBride, PhD, DSc, Mi-Heon Lee, PhD, Tania Kaprealian, MD, Simone P. Niclou, PhD, Philippe Nickers, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109418302380 |
Similar Items
-
MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and ErbB3 in Tumor-Initiating Cells
by: Bahauddeen M. Alrfaei PhD, et al.
Published: (2020-09-01) -
Usefulness of Irradiated Polyglactin 910 (Vicryl Rapide) for Skin Suturing during Surgery for Lateral Ray Polydactyly of the Toes in Children
by: Hajime Matsumine, MD, PhD, et al.
Published: (2013-09-01) -
Practical Clinical Implementation of the Special Physics Consultation Process in the Re-irradiation Environment
by: Robert A. Price, Jr., PhD, et al.
Published: (2021-01-01) -
Use of a Head-Tilting Baseplate During Tomotherapy to Shorten the Irradiation Time and Protect the Hippocampus and Lens in Hippocampal Sparing-Whole Brain Radiotherapy
by: Kosei Miura MD, et al.
Published: (2021-02-01) -
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma
by: MacLean P. Nasrallah MD, PhD, et al.
Published: (2019-05-01)